The biological and clinical significance of circulating sortilin in GBM is unclear and warrants further investigations in normal and, in particular, GBM cell lines, and further analyses of larger clinical cohort are needed to clarify the clinical biomarker value of sortilin expression (both in tissue and plasma) in GBM. Here, SORT1 is linked to glioblastoma.